UCB Biosciences Inc.
UCB Biosciences develops therapeutics for the treatment of severe, life-threatening neurological and inflammatory diseases, including epilepsy, Parkinson's disease, rheumatoid arthritis, Crohn's disease, psoriatic arthritis, lupus and osteoporosis.
Company Location
4000 Paramount Parkway, Suite 200
Morrisville
NC
27560
Phone
County
Region
Company Details
Company type
Year founded
1928
Employment range in NC
US headquarters
North Carolina
Global headquarters
Belgium
Primary site activity
All company activities
Potential end market(s)
Products on market
Briviact, Keppra, Vimpat, Neupro, Nayzilam, Cimzia, Evenity, Bimzelx
Products under development
Rozanolixizumab, Zilucoplan, Dapirolizumab pegol, Staccato® (alprazolam), Bepranemab